Fallacies of clinical studies on folic acid hazards in subjects with a low vitamin B₁₂ status

References

• Allen RH, Stabler SP, Savage DG, Lindenbaum J. 1990. Diagnosis of cobalamin deficiency I: Usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol. 34(2):90–98.
   PubMed Web of Science ®Google Scholar
• Angier RB, Boothe JH, Hutchings BL, Mowat JH, Semb J, Stokstad ELR, Subbarow Y, Waller CW, Cosulich DB, Fahrenbach MJ, et al. 1945. Synthesis of a compound identical with the L. casei factor isolated from liver. Science. 102(2644):227–228.
   PubMed Web of Science ®Google Scholar
• Baik HW, Russell RM. 1999. Vitamin B12 deficiency in the elderly. Annu Rev Nutr. 19(1):357–377.
   PubMedGoogle Scholar
• Baldwin JN, Dalessio DJ. 1961. Folic acid therapy and spinal-cord degeneration in pernicious anemia. N Engl J Med. 264(26):1339–1342.
   PubMed Web of Science ®Google Scholar
• Berk L, Bauer J.L, Castle WB. 1948. A report of 12 patients treated with synthetic pteroylglutamic acid with comments on the pertinent literature. S Afr Med J. 22(10):604–611.
   Google Scholar
• Best CN. 1959. Subacute combined degeneration of spinal cord after extensive resection of ileum in Crohn’s disease. BMJ. 2(5156):862–864.
   PubMedGoogle Scholar
• Bethell FH, Sturgis CC. 1948. The relation of therapy in pernicious anemia to changes in the nervous system. Early and late results in a series of cases observed for periods of not less than ten years, and early results of treatment with folic acid. Blood. 3(1):57–67.
   PubMed Web of Science ®Google Scholar
• Bundesinstitut für Risikobewertung. 2017. Nutzen-Risiko-Abwägung einer flächendeckenden Anreicherung von Mehl mit Folsäure: Stellungnahme Nr. 027/2017 des BfR vom 13, September 2017. BfR-Stellungnahmen. 2017:H.027p.31. http://www.bfr.bund.de/cm/343/nutzen-risiko-abwaegung-einer-flaechendeckenden-anreicherung-von-mehl-mit-folsaeure.pdf.
   Google Scholar
• Butterworth CE, Tamura T. 1989. Folic acid safety and toxicity: a brief review. Am J Clin Nutr. 50(2):353–358.
   PubMed Web of Science ®Google Scholar
• Campbell D. 2018. Folic acid to be added to UK flour in effort to reduce birth defects. Exclusive: Ministers finally overcome food industry objections on compulsory fortification. The Guardian, October 14, 2018, International edition, sec. Society.
   Google Scholar
• Campbell NR. 1996. How safe are folic acid supplements? Arch Intern Med. 156(15):1638–1644.
   PubMedGoogle Scholar
• Carmel R. 2000. Current concepts in cobalamin deficiency. Annu Rev Med. 51(1):357–375.
   PubMedGoogle Scholar
• Carmel R. 2008. How I treat cobalamin (vitamin B12) deficiency. Blood. 112(6):2214–2221.
   PubMed Web of Science ®Google Scholar
• Chodos RB, Ross JF. 1951. The effects of combined folic acid and liver extract therapy. Blood. 6(12):1213–1233.
   PubMed Web of Science ®Google Scholar
• Clarke R, Grimley Evans J, Schneede J, Nexo E, Bates C, Fletcher A, Prentice A, Johnston C, Ueland PM, Refsum H, et al. 2004. Vitamin B12 and folate deficiency in later life. Age Ageing. 33(1):34–41.
   PubMed Web of Science ®Google Scholar
• Clarke R, Bennett D. 2014. Folate and prevention of neural tube defects: Editorial. BMJ. 349(jul29 3):g4810–g4810.
   PubMedGoogle Scholar
• Clarke R, Sherliker P, Hin H, Molloy AM, Nexo E, Ueland PM, Emmens K, Scott JM, Evans JG. 2008. Folate and vitamin B12 status in relation to cognitive impairment and anaemia in the setting of voluntary fortification in the UK. Br J Nutr. 100(5):1054–1059.
   PubMed Web of Science ®Google Scholar
• Conley CL, Krevans JR. 1951. Development of neurologic manifestations of pernicious anemia during multivitamin therapy. N Engl J Med. 245(14):529–531.
   PubMed Web of Science ®Google Scholar
• Crider KS, Devine O, Hao L, Dowling NF, Li S, Molloy AM, Li Z, Zhu J, Berry RJ. 2014. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ. 349(jul29 3):g4554–g4554.
   PubMedGoogle Scholar
• Crosby WH. 1960. The danger of folic acid in multivitamin preparations. Mil Med. 125(4):233–235.
   PubMedGoogle Scholar
• Davidson LSP, Girdwood RH. 1947. Folic acid as a therapeutic agent. BMJ. 1(4504):587–591.
   PubMedGoogle Scholar
• Dickinson CJ. 1995. Does folic acid harm people with vitamin B12 deficiency? QJM. 88(5):357–364.
   PubMed Web of Science ®Google Scholar
• Diniz BSO, Yassuda MS, Nunes PV, Radanovic M, Forlenza OV. 2007. Mini-Mental State examination performance in mild cognitive impairment subtypes. Int Psychogeriatr. 19(4):647–656.
   PubMed Web of Science ®Google Scholar
• Doets EL, Ueland PM, Tell GS, Vollset SE, Nygård OK, van't Veer P, de Groot LCPGM, Nurk E, Refsum H, Smith AD, et al. 2014. Interactions between plasma concentrations of folate and markers of vitamin B(12) status with cognitive performance in elderly people not exposed to folic acid fortification: the Hordaland Health Study. Br J Nutr. 111(6):1085–1095.
   PubMed Web of Science ®Google Scholar
• Dudley GM, Coltman CA. 1970. Resolution of ineffective erythropoiesis of pernicious anemia and ‘strongly suggestive’ folate lack in response to folic acid. Am J Clin Nutr. 23(2):147–155.
   PubMed Web of Science ®Google Scholar
• Durga J, van Boxtel MP, Schouten EG, Kok FJ, Jolles J, Katan MB, Verhoef P. 2007. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet. 369(9557):208–216.
   PubMed Web of Science ®Google Scholar
• Editorial. 1947a. Folic acid. BMJ. 1(4504):604–605.
   PubMedGoogle Scholar
• Editorial. 1947b. A warning regarding the use of folic acid. New Engl J Med. 237(19):713–714.
   Web of Science ®Google Scholar
• EFSA panel on dietary products, nutrition and allergies. 2014. Scientific opinion on dietary reference values for folate. EFSA J. 12(11):3893.
   Google Scholar
• EFSA. 2009. Report prepared by the EFSA Scientific Cooperation Working Group (ESCO WG) on analysis of risks and benefits of fortification of food with folic acid. http://efsa.europa.eu.
   Google Scholar
• Ellison A. 1960. Pernicious anemia masked by multivitamins containing folic Acid. JAMA. 173(3):240–243.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. 1963. §121.1134 Pteroylglutamic acid (folic acid). Fed Registr. 28(141)July):7426.
   Google Scholar
• Food and Drug Administration. 1971. Folic acid preparations, oral and parenteral for therapeutic use; drugs for human use; drug efficacy study implementation. Fed Registr. 36 (69)April):6843–6844.
   Google Scholar
• Food and Drug Administration. 1973. Part 3 – Statements of general policy or interpretation. Subchapter B, Food and food products. Part 121 – Food additives: folic acid, potassium iodide and kelp. Fed Registr. 38 ((146)August):20725–20726.
   Google Scholar
• Food and Drug Administration. 1993. Food labeling: health claims and label statements; folate and neural tube effects. Fed Registr. 58 ((197)October):53266–53867.
   Google Scholar
• Food and Drug Administration. 1996a. Food additives permitted for direct addition to food for human consumption; folic acid (Folacin). Fed Registr. 61( (44)March):8797–8807.
   Google Scholar
• Food and Drug Administration. 1996b. Food standards: amendments of standards of identity for enriched grain products to require addition of folic acid. Fed Registr. 61 (44)March):8781–8797.
   Google Scholar
• Food and Nutrition Board, Institute of Medicine. 1998. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B₆, folate, vitamin B₁₂, pantothenic acid, biotin, and choline – A report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on folate, other B vitamins, and choline; the Subcommittee on upper reference levels of nutrients; the Food and Nutrition Board, Institute of Medicine. Washington, D.C.: National Academies Press. http://www.nap.edu/catalog/6015.
   Google Scholar
• Green R. 1995. Megaloblastic anaemia. Metabolite assays in cobalamin and folate deficiency. Baillière Best Pract Res Ckin Haematol. 8(3):533–566.
   PubMedGoogle Scholar
• Hall BE, Watkins CH. 1947. Experience with pterolyglutamic (synthetic folic) acid in the treatment of pernicious anemia. J Lab Clin Med. 32(6):622–634.
   PubMed Web of Science ®Google Scholar
• Hansen HA, Weinfeld A. 2009. Metabolic effects and diagnostic value of small doses of folic acid and B12 in megaloblastic anemias. Acta Med Scand. 172(4):427–443.
   Google Scholar
• Healton EB, Savage DG, Brust JCM, Garrett TJ, Lindenbaum J. 1991. Neurologic aspects of cobalamin deficiency. Medicine. 70(4):229–244.
   PubMed Web of Science ®Google Scholar
• Heinle RW, Dingle JT, Weisberger AS. 1947. Folic acid in the maintenance of pernicious anemia. J Lab Clin Med. 32(8):970–981.
   PubMed Web of Science ®Google Scholar
• Herbert V. 1963. Megaloblastic anemia. N Engl J Med. 268(4):201–203.
   PubMed Web of Science ®Google Scholar
• Hin H, Clarke R, Sherliker P, Atoyebi W, Emmens K, Birks J, Schneede J, Ueland PM, Nexo E, Scott J, et al. 2006. Clinical relevance of low serum vitamin B12 concentrations in older People: the Banbury B12 study. Age Ageing. 35(4):416–422.
   PubMed Web of Science ®Google Scholar
• Hughes CF, Ward M, Hoey L, McNulty H. 2013. Vitamin B12 and ageing: current issues and interaction with folate. Ann Clin Biochem. 50(4):315–329.
   PubMed Web of Science ®Google Scholar
• Israëls MCG, Wilkinson JF. 1949. Neurological complications in pernicious anaemia treated with folic acid. BMJ. 2(4636):1072–1075.
   PubMedGoogle Scholar
• Jacobson SD, Berman L. 1948. Folic acid therapy: its effect as observed in two patients with pernicious anemia and neurologic symptoms. JAMA. 137(10):825–827.
   PubMed Web of Science ®Google Scholar
• Kang JH, Irizarry MC, Grodstein F. 2006. Prospective study of plasma folate, vitamin B12, and cognitive function and decline. Epidemiology. 17(6):650–657.
   PubMed Web of Science ®Google Scholar
• Khoshnood B, Loane M, de Walle H, Arriola L, Addor M-C, Barisic I, Beres J, Bianchi F, Dias C, Draper E, et al. 2015. Long term trends in prevalence of neural tube defects in Europe: Population based study. BMJ. 351(November):h5949.
   PubMedGoogle Scholar
• Kurnick ND. 1947. Treatment of pernicious anemia with synthetic L. casei factor. Am J Med Sci. 213(6):694–708.
   PubMed Web of Science ®Google Scholar
• Langdon FW. 1905. Nervous and mental manifestations of pre-pernicious anemia. JAMA. XLV(22):1635–1638.
   Google Scholar
• Lindenbaum J, Rosenberg IH, Wilson PW, Stabler SP, Allen RH. 1994. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr. 60(1):2–11.
   PubMed Web of Science ®Google Scholar
• Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, Podell ER, Marcell PD, Stabler SP, Allen RH. 1988. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 318(26):1720–1728.
   PubMed Web of Science ®Google Scholar
• Malouf R, Evans J G. 2008. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev. (4):CD004514.
   PubMed Web of Science ®Google Scholar
• Marshall RA, Jandl JH. 1960. Responses to physiologic doses of folic acid in the megaloblastic anemias. Arch Intern Med. 105(3):352–360.
   PubMedGoogle Scholar
• Meyer LM. 1947. Folic acid in the treatment of pernicious anemia. Blood. 2(1):50–62.
   PubMed Web of Science ®Google Scholar
• Miller JW, Garrod MG, Allen LH, Haan MN, Green R. 2009. Metabolic evidence of vitamin B-12 deficiency, including high homocysteine and methylmalonic acid and low holotranscobalamin, is more pronounced in older adults with elevated plasma folate. Am J Clin Nutr. 90(6):1586–1592.
   PubMed Web of Science ®Google Scholar
• Mills JL, Dimopoulos A. 2015. Folic acid fortification for Europe? Br Med J. 351(November):h6198.
   PubMedGoogle Scholar
• Minalyan A, Benhammou JN, Artashesyan A, Lewis MS, Pisegna JR. 2017. Autoimmune atrophic gastritis: current perspectives. Clin Exp Gastroenterol. 10(February):19–27.
   PubMedGoogle Scholar
• Minot GR, Murphy WP. 2001. Treatment of pernicious anemia by a special diet. Yale J Biol Med. 74:342–353.
   Google Scholar
• Mitchell HK, Snell EE, Williams RJ. 1941. The concentration of ‘folic acid’. J Am Chem Soc. 63(8):2284–2284.
   Google Scholar
• Mitchell HK, Snell EE, Williams RJ. 1944. Folic acid. I. Concentration from spinach. J Am Chem Soc. 66(2):267–268.
   Google Scholar
• Moore CV, Bierbaum OS. 1945. The activity of synthetic Lactobacillus casei factor (folic acid) as an antipernicious anemia substance; observations on four patients; two with Addisonian pernicious anemia, one with montropical sprue and one with pernicious anemia of pregnancy. J Lab Clin Med. 30(December):1056–1069.
   PubMedGoogle Scholar
• Moore EM, Ames D, Mander AG, Carne RP, Brodaty H, Woodward MC, Boundy K, Ellis KA, Bush AI, Faux NG, et al. 2014. Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts. JAD. 39(3):661–668.
   Google Scholar
• Morris MS, Selhub J, Jacques PF. 2012. Vitamin B-12 and folate status in relation to decline in scores on the Mini-Mental State examination in the Framingham heart study. J Am Geriatr Soc. 60(8):1457–1464.
   PubMed Web of Science ®Google Scholar
• Morris MS, Jacques PF, Rosenberg IH, Selhub J. 2007. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr. 85(1):193–200.
   PubMed Web of Science ®Google Scholar
• National Toxicology Program. 2015. Identifying research needs for assessing safe use of high intakes of folic acid. U.S. Department of Health and Human Services. ntp.niehs.nih.gov/ntp/ohat/folicacid/final_monograph_508.pdf.
   Google Scholar
• Reisner EH Jr., Weiner L. 1952. Studies on the mutual effect of suboptimal oral doses of vitamin B12 and folic acid in pernicious anemia. N Engl J Med. 247(1):15–17.
   PubMed Web of Science ®Google Scholar
• Reynolds EH. 2016. What is the safe upper intake level of folic acid for the nervous system? Implications for folic acid fortification policies. Eur J Clin Nutr. 70(5):537–540.
   PubMed Web of Science ®Google Scholar
• Reynolds E. 2006. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 5(11):949–960.
   PubMed Web of Science ®Google Scholar
• Rickes EL, Brink NG, Koniuszy FR, Wood TR, Folkers K. 1948. Crystalline vitamin B12. Science. 107(2781):396–397.
   PubMed Web of Science ®Google Scholar
• Ritz ND, Meyer LM, Brahin C, Sawitsky A. 1951. Further observations on the oral treatment of pernicious anemia with subminimal doses of folic acid and vitamin B12. Acta Haematol. 5(6):334–338.
   PubMed Web of Science ®Google Scholar
• Ross JF, Belding H, Paegel BL. 1948. The development and progression of subacute combined degeneration of the spinal cord in patients with pernicious anemia treated with synthetic pteroylglutamic (folic) acid. Blood. 3(1):68–90.
   PubMed Web of Science ®Google Scholar
• Sargent FII. 1947. Folic acid: pteroylglutamic acid and related substances. N Engl J Med. 237(19):703–707.
   PubMed Web of Science ®Google Scholar
• Savage DG, Lindenbaum J. 1995. Neurological complications of acquired cobalamin deficiency: clinical aspects. Baillière’s megaloblastic anaemia. Clin Haematol. 8(3):657–678.
   Google Scholar
• Schwartz SO, Kaplan SR, Armstrong BE. 1950. The long-term evaluation of folic acid in the treatment of pernicious anemia. J Lab Clin Med. 35(6):894–898.
   PubMed Web of Science ®Google Scholar
• Scientific Advisory Committee on Nutrition. 2006. Folate and disease prevention. London: Stationary Office.
   Google Scholar
• Scientific Advisory Committee on Nutrition. 2009. Folic acid and colorectal cancer risk. Publications – GOV.UK.
   Google Scholar
• Scientific Advisory Committee on Nutrition. 2015. Folate status of women in the United Kingdom and the risk of congenital neural tube defects (NTD). https://app.box.com/s/p66yloezimv7je6s0j9l962z3gizr381/1/4509873782/42609000313/1.
   Google Scholar
• Selhub J, Rosenberg IH. 2016. Excessive folic acid intake and relation to adverse health outcome. Biochimie. [Series: One Carbon Metabolism, Vitamins B and homocysteine] 126(Supplement C):71–78.
   Google Scholar
• Selhub J, Morris MS, Jacques PF, Rosenberg IH. 2009. Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency. Am J Clin Nutr. 89(2):02S–06S.
   Web of Science ®Google Scholar
• Shane B. 2008. Folate and vitamin B12 metabolism: overview and interaction with riboflavin, vitamin B6, and polymorphisms. Food Nutr Bull. 29(2_suppl1):S5–S16.
   PubMed Web of Science ®Google Scholar
• Sheehy TW, Rubini ME, Perez-Santiago E, Santini R, Haddock J. 1961. The effect of ‘minute’ and ‘titrated’ amounts of folic acid on the megaloblastic anemia of tropical sprue. Blood. 18(6):623–636.
   PubMed Web of Science ®Google Scholar
• Spies TD, Stone RE. 1947. Liver extract, folic acid, and thymine in pernicious anaemia and subacute combined degeneration. Lancet. 249(6440):174–176.
   Google Scholar
• Spies TD, Stone RE, Lopez GG, Milanes F, Aramburu T, Lopez Toca R. 1948. The association between gastric achlorhydria and subacute combined degeneration of the spinal cord. Postgrad Med. 4(2):89–95.
   PubMedGoogle Scholar
• Tangney CC, Tang Y, Evans DA, Morris MC. 2009. Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline. Neurology. 72(4):361–367.
   PubMed Web of Science ®Google Scholar
• Thirkettle JL, Gough KR, Read AE. 1964. Diagnostic value of small oral doses of folic acid in megaloblastic anaemia. BMJ. 1(5393):1286–1289.
   PubMedGoogle Scholar
• Ungley CC, Campbell H. 1949. Subacute combined degeneration of the cord; response to liver extracts; trials with vitamin B12: quantitative method of assessing neurological status. Brain. 72(3):382–427.
   PubMed Web of Science ®Google Scholar
• Victor M, Lear AA. 1956. Subacute combined degeneration of the spinal cord: current concepts of the disease process: value of serum vitamin B12: determinations in clarifying some of the common clinical problems. Am J Med. 20(6):896–911.
   PubMed Web of Science ®Google Scholar
• Vilter CF, Vilter RW, Spies TD. 1947. The treatment of pernicious and related anemias with synthetic folic acid: observations on the maintenance of a normal hematologic status and on the occurrence of combined system disease at the end of one year. J Lab Clin Med. 32(3):262–273.
   PubMed Web of Science ®Google Scholar
• Wagley PF. 1947. Neurologic disturbances with folic acid therapy. N Engl J Med. 238(1):11–15.
   PubMed Web of Science ®Google Scholar
• Wald NJ, Morris JK, Blakemore C. 2018. Public health failure in the prevention of neural tube defects: time to abandon the tolerable upper intake level of folate. Public Health Rev. 39(1):2–11.
   PubMedGoogle Scholar
• Weißenborn A, Przyrembel H. 2005. Folsäureversorgung der Deutschen Bevölkerung: Abschlussbericht zum Forschungsvorhaben. BfR-Wissenschaft, 01/2005. Berlin: BfR, Bundesinstitut für Risikobewertung, Pressestelle.
   Google Scholar
• Whipple GH, Robscheit FS, Hooper CW. 1920. Blood regeneration following simple anemia. IV. Influence of meat, liver and various extractives, alone or combined with standard diets. Am J Physiol. 53(2):236–262.
   Google Scholar
• Wilkinson JF. 1948. Folic acid: Part I. BMJ. 1(4555):771–776.
   PubMedGoogle Scholar
• Will JJ, Mueller JF, Brodine C, Kiely CE, Friedman B, Hawkins VR, Dutra J, Vilter RW. 1959. Folic acid and vitamin B12 in pernicious anemia: studies on patients treated with these substances over a ten-year period. J Lab Clin Med. 53(1):22–38.
   PubMed Web of Science ®Google Scholar